Praluent Fate Uncertain After Amgen Wins PCSK9 Patent Battle
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi and Regeneron will appeal jury verdict that Amgen patents are valid; judge to consider permanent injunction.